CELZ — Creative Medical Technology Holdings Cashflow Statement
0.000.00%
Last trade - 00:00- $7.91m
- $0.71m
- $0.01m
Annual cashflow statement for Creative Medical Technology Holdings, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 19.2 | -10.1 | -5.29 | -5.49 | -6 |
| Amortisation | |||||
| Non-Cash Items | -21.8 | 0.069 | 0.003 | 0.037 | 0.002 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.249 | 2.19 | -2.84 | 0.045 | 0.013 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -2.22 | -7.8 | -8.03 | -5.3 | -5.86 |
| Capital Expenditures | 0 | — | -0.1 | — | — |
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | — | -10.1 | 3.55 | 6.32 | -0.051 |
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 0 | -10.1 | 3.45 | 6.32 | -0.051 |
| Financing Cash Flow Items | -0.548 | 0 | — | — | 0.01 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 12.8 | 15.5 | -0.271 | 1.45 | 7.17 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 10.6 | -2.4 | -4.85 | 2.47 | 1.27 |